Education
About Us
Working with TipRanks
Follow Us
dorsaVi Limited (AU:DVL)
ASX:DVL
DVL Stock Chart & Stats
Day’s Range― - ―
52-Week Range<AU$0.01 - AU$0.02
Previous CloseN/A
Volume925.00K
Average Volume (3M)1.31M
Market Cap
AU$11.70M
Enterprise ValueN/A
Total Cash (Recent Filing)AU$1.24M
Total Debt (Recent Filing)AU$131.48K
Price to Earnings (P/E)―
Beta-0.10
Next Earnings
Aug 27, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding731,237,900
10 Day Avg. Volume3,052,155
30 Day Avg. Volume1,310,851
Financial Highlights & Ratios
PEG Ratio-0.36
Price to Book (P/B)3.45
Price to Sales (P/S)0.00
P/FCF Ratio-9.25
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
dorsaVi Limited News
PremiumCompany Announcements
dorsaVi Limited Initiates Trading Halt for Major Announcement
PremiumCompany Announcements
dorsaVi Expands Reach with New SANO Health Partnership
PremiumCompany Announcements
dorsaVi Expands AI Platform into Workplace Safety Market
PremiumCompany Announcements
dorsaVi Advances AI Movement Analysis and Launches New ACL Injury Test
PremiumCompany Announcements
dorsaVi Limited Announces Cessation of Securities
PremiumCompany Announcements
dorsaVi Unveils Revolutionary 3D Motion Analysis to Combat ACL Injuries
PremiumCompany Announcements
dorsaVi Partners with Renowned US Surgeon for Athlete Movement StudyOptions Prices
Currently, No data available
---
Ownership Overview
5.90% Insiders
―
Mutual Funds
― Other Institutional Investors
94.10% Public Companies and
Individual Investors
DVL FAQ
What was dorsaVi Limited’s price range in the past 12 months?
dorsaVi Limited lowest share price was <AU$0.01 and its highest was AU$0.02 in the past 12 months.
What is dorsaVi Limited’s market cap?
dorsaVi Limited’s market cap is AU$11.70M.
When is dorsaVi Limited’s upcoming earnings report date?
dorsaVi Limited’s upcoming earnings report date is Aug 27, 2025 which is in 78 days.
How were dorsaVi Limited’s earnings last quarter?
dorsaVi Limited released its earnings results on Feb 26, 2025. The company reported -AU$0.001 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.001.
Is dorsaVi Limited overvalued?
According to Wall Street analysts dorsaVi Limited’s price is currently Overvalued.
Does dorsaVi Limited pay dividends?
dorsaVi Limited does not currently pay dividends.
What is dorsaVi Limited’s EPS estimate?
dorsaVi Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does dorsaVi Limited have?
dorsaVi Limited has 731,237,900 shares outstanding.
What happened to dorsaVi Limited’s price movement after its last earnings report?
dorsaVi Limited reported an EPS of -AU$0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of dorsaVi Limited?
Currently, no hedge funds are holding shares in AU:DVL
dorsaVi Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:DVL Sentiment 100%
Sector Average 68%
Sector Average 68%
Insider Transactions
Bought Shares
Worth AU$95.0K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
―
20 days / 200 days
Momentum
33.33%
12-Months-Change
Fundamentals
Return on Equity
-74.01%
Trailing 12-Months
Asset Growth
6.62%
Trailing 12-Months
Company Description
dorsaVi Limited
dorsaVi Limited (DVL) is a technology company specializing in wearable sensor technology and software solutions that capture and analyze movement and muscle activity. The company operates primarily in the healthcare, occupational health and safety, and sports sectors, providing products and services that help improve clinical outcomes, optimize performance, and enhance workplace safety. Its core products include wearable sensors and accompanying software platforms that offer detailed insights into human movement and ergonomics.
Technical Analysis
Impedimed Limited
―
Resonance Health Ltd
―
PYC Therapeutics Limited
―
Race Oncology Ltd.
―
Botanix Pharmaceuticals Limited
―